B of A Securities Rates Guardian Pharmacy Services (GRDN) buy
Analyst Allen Lutz maintains a buy rating on Guardian Pharmacy Services with a $47.00 price target as shares trade near $42.42, a 10.80% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
B of A Securities rated Guardian Pharmacy Services, Inc. ($GRDN) "buy" with a $47 price target on June 17, 2026.
Since the rating, $GRDN is down 11.7% after 1 week, down 6.6% after 1 month and down 9.1% to date (from the $43.40 close on Jun 17, 2026).
GRDN
Guardian Pharmacy Services, Inc.
Key Points
- B of A Securities analyst Allen Lutz reiterated a buy rating on Guardian Pharmacy Services (NYSE: GRDN) with a $47.00 price target on June 17, 2026.
- B of A Securities's $47 price target implies 10.80% upside from Guardian Pharmacy Services, Inc.'s ($GRDN) current $42.42 share price.
- The stock recently traded at $42.42, sitting below the B of A target and well within its 52-week range of $23.14 to $48.33.
- Wall Street maintains a strong buy consensus on the stock across six analyst opinions, with price targets stretching as high as $51.00.
Get $GRDN trade alerts by text
We text you when insiders, Congress or big funds trade $GRDN. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Guardian Pharmacy Services, Inc. alert may contain errors. Disclosures
B of A Securities Stays Bullish on Guardian Pharmacy Stock
On June 17, 2026, B of A Securities analyst Allen Lutz kept a buy rating on Guardian Pharmacy Services, Inc. (NYSE: GRDN), holding the price target steady at $47.00. This update puts the firm's goal above where the shares currently change hands, giving investors a clear look at how one major shop views the pharmacy service provider's upside from current levels.
$GRDN price target
Guardian Pharmacy Services, Inc. daily closes and this analyst's $47 target. Not advice.
Guardian Pharmacy Stock Trades Near $42
The shares recently traded at $42.42, putting them comfortably above the 50-day moving average of $40.57 and the 200-day moving average of $36.59. The stock has moved between a 52-week low of $23.14 and a 52-week high of $48.33. With the $47.00 target from B of A sitting just a few dollars under that yearly peak, the call points to continued confidence in the firm's upward path.
Other Wall Street Firms Update Their Views
Other major investment banks have also weighed in on the pharmacy operator in recent weeks. On September 23, 2026, Keybanc started coverage with an overweight rating and a $52.00 price target. Before that, Truist Securities kept its buy rating on September 21, 2026, and raised its target to $51.00 from $47.00. Oppenheimer also kept an outperform rating on August 7, 2026, lifting its target to $49.00 from $43.00.
Guardian Pharmacy Services Business Profile
Headquartered in Atlanta, Georgia, Guardian Pharmacy Services runs a network that delivers technology-enabled pharmacy services to long-term care facilities across the United States. The company builds specialized tools to help assisted living centers, behavioral health facilities, and group homes manage medications safely and efficiently. Founded in 2003, the enterprise employs about 3,600 workers to support its clinical drug dispensing and software offerings.
What to Watch Next for GRDN
Investors tracking the stock will want to watch for the company's next financial results, which are slated for release after the market closes on November 9, 2026. Market watchers will also keep an eye on whether trading volume pushes the equity closer to the consensus targets set by Wall Street analysts.
Related Filing Alerts
Source: B of A Securities's rating change on $GRDN (Jun 17, 2026). Written by software, not financial advice. How we make alerts